Nocturne Acquisition Corp

Nocturne Acquisition Corp. is a blank check formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 28, 2020 and is headquartered in Wilmington, DE.

Nocturne Acquisition Corp - Unit

Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and degenerative neurological conditions (such as Alzheimer's and Parkinson's disease), epilepsy, and stroke. Cognos' lead product candidate is the SINNAISTM Implantable Smart Pump, believed to be the world's first implantable device under development for the metronomic delivery of therapeutics for neurological diseases, including brain cancer.

News for Nocturne Acquisition Corp Stock (MBTC)